Abiopharma

Appia is a Canadian company listed on the Canadian Stock Exchange (CSE:API), the OTCQX (APAAF) and in Germany. The Company is currently delineating high-grade critical Rare Earth Elements at Alces Lake, just northwest of the Athabasca Basin, Saskatchewan, as well as exploring several highly prospective Uranium prospects in over 600 square km in the same area. The Company also has a 100% interest in 31,000 acres, including Rare Earth Element and Uranium deposits over five mineralized zones in the Elliot Lake Camp, Ontario, which historically produced over 300 million pounds of Uranium oxide and is the only Canadian camp that has had significant rare earth element (Yttrium) production. The deposits are largely unconstrained along strike and down dip. The Company holds the right to acquire up to a 70% interest in the PCH Rare Earths Project which is 40,963 ha. in size and is located within the Goias State of Brazil.

Additional info from OTC:
Appia is a Canadian company listed on the Canadian Stock Exchange (CSE:API), the OTCQX (APAAF) and in Germany. The Company is currently delineating high-grade critical Rare Earth Elements at Alces Lake, just northwest of the Athabasca Basin, Saskatchewan, as well as exploring several highly prospective Uranium prospects in over 600 square km in the same area. The Company also has a 100% interest in 31,000 acres, including Rare Earth Element and Uranium deposits over five mineralized zones in the Elliot Lake Camp, Ontario, which historically produced over 300 million pounds of Uranium oxide and is the only Canadian camp that has had significant rare earth element (Yttrium) production. The deposits are largely unconstrained along strike and down dip. The Company holds the right to acquire up to a 70% interest in the PCH Rare Earths Project which is 40,963 ha. in size and is located within the Goias State of Brazil.